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Abstract
Background: MicroRNAs (miRNAs) are regulatory molecules that play an important role in many physiological
processes, including cell growth, differentiation, and apoptosis. In addition to modulating normal cellular functions,
it has also been reported that miRNAs are involved in the development of many pathologies, including
cardiovascular diseases, cancer, inflammation, and neurodegeneration. Methods for the sensitive detection and
measurement of specific miRNAs and their cellular targets are essential for both basic research endeavours, as well
as diagnostic efforts aimed at understanding the role of miRNAs in disease processes.
Findings: In this study, we describe a novel, imaging cytometry-based protocol that allows for simultaneous
visualisation and quantification of miRNAs and their putative targets. We validated this methodology in a neuronal
cell line by examining the relationship of the miRNA miR-124 and its known target, cyclin dependent kinase 6
(CDK6). We found that ectopic overexpression of miR-124 resulted in the downregulation of CDK6, decreased
cellular proliferation, and induced cellular morphological changes.
Conclusions: This method is suitable for analysing the expression and cellular localisation of miRNAs and target
proteins in small cell subsets within a heterogeneous cell suspension. We believe that our cytometry-based
methodology will be easily adaptable to miRNA studies in many areas of biomedical research including
neuroscience, stem cell biology, immunology, and oncology.
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Background
MiRNAs are small (18-23 nucleotides) non-coding
RNAs that regulate the expression of target genes by
binding to complementary mRNAs. Binding of an
miRNA to its target mRNA leads to either degradation
of the mRNA or prevention of its translation [1]. As the
study of miRNAs has advanced, it has become evident
that these molecules play crucial roles in myriad tissues,
including those of the nervous system [1,2]. MiRNAs
have been shown to play an important role in cell
differentiation, proliferation, and apoptosis [3]. More-
over, deregulation of specific miRNA expression has
been connected to several pathologies, including cancer,
inflammation, and neurodegenerative disease [4-6].
As interest in the mechanisms and clinical relevance
of miRNA-mediated gene regulation increases, there is a
demand for new methods that can quantitatively
assesses the expression levels of specific miRNAs and
their target genes in various subsets of cells. Current
methods for measuring the expression of miRNAs
include quantitative real-time PCR (qPCR) and in situ
hybridisation with specific probes [7,8]. Although qPCR
is a sensitive and quantitative method, it does not allow
for the measurement of miRNA levels in specific cell
subsets within a heterogeneous cell population, nor does
* Correspondence: eponomarev@partners.org; barteneva@idi.harvard.edu
1Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA, USA
2Immune Disease Institute and Program in Cellular and Molecular Medicine,
Children’s Hospital Boston, Boston, MA, USA
Full list of author information is available at the end of the article
Ponomarev et al. BMC Research Notes 2011, 4:517
http://www.biomedcentral.com/1756-0500/4/517
© 2011 Ponomarev et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.it allow for the visualisation of specific miRNA species
in particular cellular compartments of sorted cells.
Other methods, such as in situ hybridisation, are cap-
able of assessing miRNA expression in specific cell
types within tissue sections, but this method is not
entirely quantitative, as either semiquantitative western
blotting or a recently developed quantitative TaqMan
Protein Assay are used to measure target protein levels
in the entire cell population rather than in individual
cells [9]. Recently described microscopy-based methods
allow for the detection of both miRNAs and their tar-
g e t si nt i s s u es e c t i o n s[ 1 0 ] .H o w e v e r ,t oo u rk n o w l -
edge, no cytometry-based quantitative methods have
been described in which the expression of miRNAs
and their targets can be measured simultaneously in a
single cell. We believe that such methods would be
extremely valuable for in vivo studies of miRNA func-
tion in a heterogeneous cell population, particularly in
the case of clinical specimens. Quantitative imaging
cytometry with the ImageStream system allows for
quantitative evaluation of internalisation, co-localisa-
tion, and trafficking of proteins in various cellular
compartments [11-13] and is a method of choice due
to its ability to combine morphometric analysis of
images with the statistical analysis of a large number
of cells (reviewed by Zuba-Surma et al [14].).
The miRNA miR-124 is known to be expressed in
the CNS by mature neurons and plays an important
role in the differentiation of neuronal progenitors to
neurons by targeting several genes, including CDK6
[15,16]. CDK6 is a member of the family of serine-
threonine kinases that controls cell cycle progression
in many cell types, including neuronal cells [17]. It has
b e e ns h o w nt h a ti n h i b i t i o no fC D K 6e x p r e s s i o nb y
miR-124 prevents the growth of medulloblastomas that
comprise approximately 20% of primary paediatric
brain tumors [16].
In this study, we demonstrate that the expression of
miR-124 in a neuronal cell line is inversely correlated
with expression of CDK6 in individual cells, and that
miR-124 overexpression downregulates CDK6, decreases
cell proliferation and promotes apoptosis. This was
achieved by employing a novel imaging cytometry-based
methodological approach that allows for the simulta-
neous visualisation and quantification of a specific
miRNA and its target in individual cells.
Materials and methods
Cells
Mouse neuroblastoma NIE115 cells were purchased
from ATCC (Manassas, USA) and were maintained in
DMEM (ATCC) with 10% FBS (Invitrogen, Carlsbad,
USA).
Antibodies and reagents
A rabbit anti-CDK6 primary antibody (sc-117, used at a
dilution of 1:50) was purchased from Santa Cruz Bio-
technology (Santa Cruz, USA). The secondary goat anti-
rabbit IgG Alexa Fluor 660 conjugated antibody (highly
cross- adsorbed, used at a dilution of 1:500) was pur-
chased from Invitrogen (Carlsbad, USA). MiR-124-FITC
(cat#38507-04, C = 25 μM), scrambled-miR-FITC
(cat#99004-04, C = 25 μM), and miRCURY™ locked
nucleic acid (LNA) detection probes were purchased
from Exiqon (Woburn, USA) and used at a dilution of
1:100. Hybridisation buffer (25% formamide, 15 mM
NaCl and 10% dextran sulphate) was prepared as
described previously [8].
Staining for miR-124 and CDK6
The NIE115 cells were washed with PBS and permeabi-
lised using the BrdU Flow kit (BD Biosciences, San Jose,
USA) according to the manufacturer’s instructions.
After washing with Perm/Wash Buffer from the BrdU
Flow kit, the cells were incubated in Perm/Wash buffer
containing 50% goat serum for 20 min, after which the
anti-CDK6 antibody was added. The cells were incu-
bated with the primary antibody for 30 min at 20°C
(room temperature), washed twice with Perm/Wash buf-
fer, and then incubated with the AlexaFluor 660-conju-
gated secondary antibody in Perm/Wash Buffer at 20°C
for 20 min. After incubation, the cells were washed
twice in Perm/Wash Buffer and fixed with 1% parafor-
maldehyde in PBS for 15 min on ice. After fixation, the
cells were washed with PBS and resuspended in hybridi-
sation buffer. The cells were incubated for 30 min at 53°
C followed by the addition of miR-124-FITC or
scrambled-miR-FITC probes. The cells were incubated
with the probes for 1 h at 53°C and then washed twice
with 1X saline-sodium citrate (SSC) buffer at 53°C,
washed once with 0.1× SSC buffer at 53°C, washed once
with PBS at 20°C, and finally resuspended in 1% parafor-
maldehyde in PBS. The cells were stored at 4°C until
analysis.
Transfection with miR-124
5-10 × 10
6 neuroblastoma NIE115 cells were transfected
with 50 nM of a miR-124a duplex that mimics pre-miR-
124a (sense 5’-UAAGGCACGCGGUGAAUGCC-3’,
antisense: 3’-UUAUUCCGTGCGCCACUUAC-5’,I n v i -
trogen, Carlsbad, USA), using Lipofectamine 2000™
(Invitrogen, Carlsbad, USA) according to the manufac-
turer’s instructions. As a negative control for miR-124,
control miRNA (Negative Control#1, sense: 5’-AGUA-
CUGCUUACGAUACGGTT-3’,a n t i s e n s e :5 ’-CCGUAU
CGUAAGCAGUACUTT-3’, Invitrogen, Carlsbad, USA)
was used. Cells were analysed 48 h post-transfection.
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Proliferation was assessed by examining bromodeoxyuri-
dine (BrdU) incorporation 14 h after the addition of
BrdU to the neuroblastoma cell culture. Analysis of
BrdU labelling of cells was performed using the BrdU
Flow kit from BD Biosciences (San Jose, USA) according
to the manufacturer’s instructions.
Quantitative imaging flow cytometry
After staining for miR-124 and CDK-6 and fixation, cells
were adjusted to 10
7 cells/ml and transferred to 500 μl
siliconised microcentrifuge tubes (Sigma, St Louis, USA)
f o ra n a l y s i so na nI m a g e S t r e am 100 imaging cytometer
(Amnis Inc, Seattle, USA). We successfully used the
AMNIS cytometer in our previous applications to study
the extent of transfection of macrophages with micro-
RNA-124 [5]. The ImageStream was equipped with 488,
658, and 405 nm laser sources with variable laser power
(from 20 to 200 mW for the 488 nm laser and from 20
to 90 nm for the 658 nm laser) and a brightfield light
source. Files of 10,000-20,000 events were acquired for
each sample and 200-500 events were acquired for sin-
gle fluorochrome controls. Single colour controls were
collected first to set the optimal laser power and to
avoid saturation of the camera. Additional single colour
control files were collected in the absence of brightfield
illumination for use in creating the compensation matrix
with IDEAS software (Amnis, Seattle, USA). The calcu-
lated compensation matrix was applied to all files to
correct for spectral crosstalk. The resulting compensated
cytometry data were further analysed with the IDEAS
software program. Gating of cell events with the area
and aspect ratio was used to eliminate debris (low area)
and multi-cellular events (large area, high aspect ratio)
from further analysis, as has been described before [13].
After defining single, focused cells, the identification of
appropriate cell subpopulations was done by analysing
the cells labelled for BrdU, CDK6, and/or miR-124. The
ratio of the fluorescent pixel intensity to the area of the
cell in their respective channels was analysed for miR-
124 and CDK6 staining using the IDEAS software.
Results
Expression of miR-124 is inversely correlated with the
expression of CDK6
We initially developed techniques for single staining of
CDK6 or miR-124. By employing a matched isotype
control antibody, we established that preliminary block-
ing of permeabilised samples with 50% goat serum
eliminated non-specific binding of the anti-CDK6 pri-
mary antibody, but did not perturb our ability to sensi-
tively detect CDK6 protein in the cells, as shown in
Additional file 1: Figure S1a. For miR-124 detection, we
adapted a histological method for in situ hybridisation
to the analysis of the cell suspension, and adjusted the
temperature of hybridisation and the concentration of
the probe. As a control for non-specific binding of the
miR-124-FITC LNA probe, we used the scrambled-miR-
FITC LNA probe from the same company (Exiqon). We
found that at a dilution of 1:100 and at a hybridisation
temperature of 53°C, binding of the non-specific
scrambled-miR-FITC LNA probe (SCR probe) was prac-
tically undetectable, while binding of the miR-124-FITC
LNA probe (miR-124 probe) was easily detectable
(Additional file 1: Figure S1b).
A critical component of our desired methodology was
the combined detection of CDK6 and miR-124 in single
cells. The hybridisation conditions for the miR-124
probe included the presence of formamide in the hybri-
disation buffer and high temperature (53°C) which likely
resulted in the denaturation of CDK6 and substantially
decreased antibody staining (data not shown). To avoid
this complication, we performed staining for CDK6 and
fixation, followed by hybridisation with the miR-124
probe as a sequential step. Our approach is different
from previously published methods for miRNA analysis
in tissue sections where staining with antibodies for a
target protein was performed after hybridisation with a
probe for miRNA [17]. We found that our approach
produced bright staining for CDK6 before and after
hybridisation conditions (Additional file 1: Figure S1c).
We also compared the fluorescence intensity of miR-
124 expression in control cells or cells transfected with
miR-124 using a FITC-labelled probe for miR-124. We
found that miR-124 transfected cells became smaller in
size and had a comparable level of overall fluorescence
for the miR-124-FITC probe, but most of the cytoplas-
mic areas were brighter in miR-124 transfected cells, as
shown in Additional file 1: Figure S1d. We also selected
two fluorophores with practically no spectral overlap on
the ImageStream 100 cytometer (FITC and Alexa Fluor
660), which eliminated spectral compensation issues.
Finally, we measured the expression of miR-124 and
CDK6 in an experimental setup typically used in the
field of miRNA analysis; thus, we compared the level of
expression of both molecules in cells transfected with
control miRNA or miR-124. The relative level of expres-
sion was evaluated by the ratio between two parameters:
fluorescence intensity and the area of fluorescent signal
in respective channels. We found that in the control
cells there was a distinct distribution pattern for the
expression of miR-124 and CDK6, resulting in four dis-
tinguishable subsets: cells that expressed high levels of
CDK6 and low or intermediate levels of miR-124 (Figure
1a, gate R1), cells that expressed low levels of CDK6 and
low levels of miR-124 (Figure 1a, gate R2), cells that
expressed low levels of CDK6 and intermediate levels of
miR-124 (Figure 1a, gate R3), and cells that expressed
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1a, gate R4). Representative images of cells from each
region are shown in Figure 1c. In the R1 region cells
(miR-124
low/intCDK6
hi), miR-124 was located primarily
in the cytoplasm, which is consistent with the known
pattern of miRNA localisation. R2 region cells (miR-
124
lowCDK6
low) were likely apoptotic, as these cells had
all the morphological characteristics of cells undergoing
apoptosis such as small size, absent nuclei, and low
expression levels of both miR-124 and CDK6. The cells
from regions R3 (miR-124
intCDK6
low) and R4 (miR-
124
hiCDK6
low) had intermediate and high levels of miR-
124 expression, respectively, and low levels of CDK6.
Thus, our analysis demonstrated that in a population of
neuroblastoma cells, there is an inverse correlation
between miR-124 expression and CDK6 expression in
individual cells: cells with high levels of CDK6 had low
or intermediate levels of miR-124 expression (Figure 1a,
gate R1), whereas most of the cells with intermediate
and high levels of miR-124 expressed low levels of
C D K 6( F i g u r e1 a ,g a t eR 3 - R 4 ) .W ef o u n daf e wc e l l s
that were miR-124
hiCDK6
hi,s h o w ni nF i g u r e1 ai nt h e
upper right quadrant as green dots. These cells repre-
sented dividing cells (Additional file 2: Figure S2a) or
cell doublets consisting of two cells, one of which was
CDK6
hi while the other was miR-124
hi (Additional file
2: Figure S2b). These studies demonstrate the utility of
combined cytometry-based miRNA and target detection.
It is critical to note that several parameters should be
optimised in performing this method. Precise incubation
times and temperature control are crucial for obtaining
reproducible data, and single-colour control samples are
necessary to exclude saturation events and to optimise
laser power. In addition, the use of fluorochromes that
minimise spectral overlap will help ensure that miRNA
and target detection is sensitive and robust.
Overexpression of miR-124 resulted in the downregula-
tion of CDK6. When we compared the level of expres-
sion of CDK6 in “control” cells versus cells transfected
with miR-124, we found that the CDK6
hi population
was significantly reduced (from 38 to 2% for gate R1)
(Figure 1a, b). This suggests that overexpression of miR-
124 resulted in downregulation of CDK6 in the entire
population of the cells. We found that the number of
cells with a small size and low levels of miR-124 and
CDK6 was substantially increased (from 9 to 36%) (Fig-
ure 1a, b; gate R2). We speculated that the increase in
the number of miR-124
lowCDK6
low cells in gate R2
upon miR-124 overexpression was due to enhanced
apoptosis. In support of this hypothesis, we found that
these cells had all the morphological characteristics of
cells undergoing apoptosis (Additional file 3: Figure S3,
R2: miR-124
lowCDK6
low). Representative images of cells
from the other regions after transfection with miR-124
are shown in Additional file 3: Figure S3. As is readily
apparent, miR-124-transfected cells were smaller in
comparison to “control” cells, and contained relatively
high levels of miR-124 and low levels of CDK6 (Addi-
tional file 1 Figure S1, R3-R4). The average percentage
of cells in regions R1-R4 for control cells vs. cells trans-
fected with miR-124 is summarised in Figure 1d. Thus,
our cytometry-based method was able to effectively
demonstrate that overexpression of miR-124 results in
decreased expression of CDK6 in a neuronal cell line.
Overexpression of miR-124 inhibits cellular proliferation
Since CDK6 is a well-characterised mediator of cell
cycle progression, we compared the proliferation of cells
transfected with control miRNA versus cells transfected
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Figure 1 Analysis of the expression of miR-124 and CDK6 in
neuroblastoma cells transfected with control miRNA (a) and
miR-124 (b). The cells were transfected and stained for miR-124
and CDK6 as described in Materials and Methods. The relative
fluorescence intensity level for miR-124-FITC (x-axes) vs. CDK6-AF660
(y-axes) is shown in (a) and (b). Representative images of cells from
“control” cell subpopulations-miR-124
low/intCDK6
hi (gate R1); miR-
124
lowCDK6
low(gate R2); miR-124
intCDK6
low (gate R3); and miR-
124
hiCDK6
low (gate R4)-are shown in (c). The data is representative
of four separate experiments. The average percentages for subsets
from gates R1-R4 is shown in (d).I n( c) the expression of miR-124 is
shown in green and the expression of CDK6 is shown in red.
Merged images show the expression of both CDK6 and miR-124.
Three representative images are shown for each subset
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assay. We found that overexpression of miR-124
decreased the percentage of BrdU
+ cells 14 h post-BrdU
treatment by 5.4-fold (from 8.1 to 1.5%), as shown in a
representative experiment in Figure 2b (gates R1 and
R2). Interestingly, the “control” BrdU
+ cells were larger
in size (Figure 2a, gate R2) and showed nuclear BrdU
localisation (Figure 2c; BrdU
+,g a t eR 2 ) ,w h i l em o s to f
the BrdU
+ cells in the miR-124-transfected population
were smaller in size (Figure 2d, gate R1) and exhibited
BrdU throughout the cytoplasm (Figure 2d; BrdU
+, gate
R1). This suggests that most of the BrdU
+ cells in the
miR-124-transfected population were apoptotic, as the
nuclear membrane disappears during apoptosis. This is
consistent with previous results that demonstrated that
transfection of NIE115 cells with miR-124 results in an
increase in the number of cells that have an apoptotic
morphology (Figure 1a-d; gate R2). Thus, transfection of
neuroblastoma cells with miR-124 results in a decrease
in cell proliferation and an increase in apoptosis, which
is in concordance with the downregulation of CDK6 by
miR-124.
Discussion
We have demonstrated that the imaging cytometry
approach described in this report can be used for sensi-
tive and quantitative evaluation of miRNA and target
expression in individual cells. This method may also be
useful for the validation of predicted target genes. The
use of a fluorescently-labelled miRNA probe in combi-
nation with a fluorochrome-conjugated antibody to the
miRNA-targeted gene product and excitation from dif-
ferent lasers (488 nm and 658 nm, respectively) made it
possible to provide good signal separation with little
effect on the overall fluorescent signal. Important fea-
tures of this technique include i) its feasibility for the
analysis of very small numbers of cells and ii) its suit-
ability for detailed characterisation of miRNA and target
expression in diverse cell subsets through the use of
fluorochrome-conjugated antibodies specific for surface
markers. This methodology will be particularly useful
for the analysis of miRNA expression/function in
immune and stem cells, as well as cells obtained from
solid tissues and tumours. We did not experience any
methodological difficulties or reduced effectiveness of
the method for primary isolated cells when compared to
cultured cells, since all the procedures, including cell
fixation, permeabilisation, staining with antibodies, and
the process of hybridisation with the miRNA-specific
probes are virtually identical for primary isolated and
cultured cells.
Our new imaging cytometry-based approach has sev-
eral other advantages over currently used methods for
the quantification of miRNA expression and its puta-
tive targets. Use of qPCR or proteomics-based assays
presume the destruction of the tissue under examina-
tion and, even if these assays are combined with FACS
(including single-cell qPCR and sensitive mass-spectro-
metry analysis), these methods do not allow for simul-
taneous measurement of specific miRNA and/or target
levels and the analysis of miRNA and target protein
distribution in cellular compartments. By using this
imaging cytometer-based protocol, part of the pro-
cessed sample can be used for quantification by qPCR
and/or parallel analysis by conventional flow
cytometry.
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Figure 2 Comparison of the level of proliferation of
neuroblastoma cells transfected with control miRNA (a) and
miR-124 (b). The cells were transfected and proliferation was
assessed by the BrdU incorporation assay as described in Materials
and Methods. The cell size (area of the cell) and the BrdU-FITC
fluorescence intensity are shown along the x-axis and y-axis,
respectively, in (a) and (b). There representative experiment is
shown in (a and b) and mean ± S.E. of three separate experiments
is shown in (c). Representative images of BrdU
- (negative) and BrdU
+ (positive) cells of small size (gate R1) and large size (gate R2) are
shown in (c). In (c) the expression of BrdU is shown in green and
the bright field image of the cells is shown in grey. Three
representative images are shown for each subset. In (d), the bright
field images of the cells are shown in grey (left images), the
expression of BrdU is shown in green (middle images) and merged
images are shown on the right. Three representative images are
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scopy-based methods combined with multicolour ima-
ging for the detection of miRNA and its targets [10,18].
These new methods allow for simultaneous analysis of
miRNA and putative target expression in tissue sections.
Special software enables per-cell analysis that can be
displayed as a scatter plot in a manner similar to the
presentation of flow cytometry data [10]. Although these
methods can be used for the analysis of cells in tissues
that cannot be isolated as cell suspensions (e.g. adult
brain), they also have several shortcomings. First, micro-
scopy-based methods preclude the analysis of statisti-
cally powerful cell numbers, as at most several hundred
cells can be realistically analysed in comparison to tens
or even hundreds of thousands of events with flow and
imaging cytometry. Secondly, staining of tissue sections
regularly conjures artefacts that negatively affect immu-
nofluorescence analysis, making it difficult to either use
certain antibodies to measure the expression of the tar-
get protein or to identify particular cell types [19].
Third, the flow imaging cytometer has all the flexibility
of a regular flow cytometer, allowing problems con-
nected with signal amplification and spectral compensa-
tion to be overcome, and facilitating the detection of
even weak fluorescent signals. Although we analysed our
samples on an imaging cytometer, a conventional flow
cytometer is perfectly suitable for most of the data col-
lection and analysis, allowing the methodology outlined
here to be employed by many scientists who only have
access to standard FACS equipment.
In conclusion, we believe that the method described in
this manuscript will be of great value for functional stu-
dies of the roles miRNAs play in many areas of biology
and biomedicine, including the immune response, can-
cer development, stem cell generation, cell growth and
differentiation, apoptosis, and neurogenesis.
Additional material
Addtional file 1: Single stain controls for detection of CDK6 and
miR-124. (A) Neuroblastoma cells were fixed, permeabilized, blocked
with 50% goat serum and stained with anti-CDK6 or Isotype control as
described in Materials and methods. The histograms with anti-CDK6
staining are shown on the top and staining for with isotype control is
shown on the bottom. (B) Neuroblastoma cells were fixed, permeabilized
and then were subjected to hybridization with miR-124-FITC LNA (miR-
124 probe, top histogram) or scrambled-miR-FITC LNA (SCR probe,
bottom histogram) probes as described in Materials and Methods. (C)
Representative images of the cells stained with anti-CDK6 antibodies
before (left) and after (right) the cells were subjected co conditions for
hybridization with LNA probes are shown. (D) Comparison of cell
morphology and miR-124 expression in the cells that were transfected
with Control miRNA (left) or miR-124 (right). The cells were transfected as
described in Materials and methods and then cells were subjected to
hybridization with miR-124-FITC LNA probe.
Addtional file 2: Characterization of minor population of miR-
124
hiCDK6
hi cells. Representative images of miR-124
hiCDK6
hi subset of
control cells (indicated as green dots in upper right quadrant of Figure
1A) are shown. Most of the events in miR-124
hiCDK6
hi subset represent
cell doublets either as dividing cells (A) or cell aggregates (B).
Addtional file 3: Representative images of miR-124-transfected cells
from miR-124
lowCDK6
low (gate R2), miR-124
intCDK6
low (gate R3) and
miR-124
hiCDK6
low (gate R4) subsets are shown. The cells were
transfected with miR-124 and 48 hours later were stained for miR-124
and CDK6 as described in Materials and Methods. Staining for miR-124 is
shown in green and staining for CDK6 is shown in red. Merged images
show staining for both CDK6 and miR-124. Three representative images
are shown for each subset.
List of abbreviations
BrdU: Bromdeoxyuridine; CDK: Cycline dependent kinase; CNS: Central
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